Baidu
map

Microcirculation:新诊断法可降低严重妊娠期高血压发病风险

2013-12-05 刘石磊 新华社

先兆子痫是一种严重的妊娠期高血压疾病,可危及母婴生命安全。英国研究人员11月5日报告说,他们研发出一种新的诊断方法,可通过血检快速准确地判断发病风险,从而尽早预防。据介绍,孕妇先兆子痫发病率大约为2%至10%,是造成孕妇死亡的一大病因,也是造成胎儿死亡或畸形的重要原因之一。 【原文下载】 英国盖氏医院等机构的研究人员在新一期美国心脏病学会杂志《循环》上发表论文说,由于缺乏有效治疗手段,

先兆子痫是一种严重的妊娠期高血压疾病,可危及母婴生命安全。英国研究人员11月5日报告说,他们研发出一种新的诊断方法,可通过血检快速准确地判断发病风险,从而尽早预防。

据介绍,孕妇先兆子痫发病率大约为2%至10%,是造成孕妇死亡的一大病因,也是造成胎儿死亡或畸形的重要原因之一。 【原文下载】 

英国盖氏医院等机构的研究人员在新一期美国心脏病学会杂志《循环》上发表论文说,由于缺乏有效治疗手段,发生先兆子痫后只能中止妊娠,因此早期诊断十分关键。研究人员说,传统诊断法包括血压检测及通过尿检测试蛋白含量,但准确率不高,且无法判断严重程度。

研究人员发现,胎盘生长因子水平是更为清晰准确的参考指标。这一水平过低预示着较高的先兆子痫风险,有必要尽早采取措施,而如果该指标正常或偏高,即使伴有其他传统指标不正常现象,也无须中止妊娠。

研究人员说,测试胎盘生长因子只需通过简单血检,且15分钟内即可测出结果,准确率高达96%左右。领导这项研究的安德鲁·申南教授说,新的测试方法不仅便捷而且费用低廉,更重要的是可以明确反映先兆子痫的发病风险,有助于医生作出更准确合理的判断,让母婴避免不必要的伤害。

原文出处


Brennan LJ, Morton JS, Davidge ST.Vascular Dysfunction inPreeclampsia.Microcirculation. 2013 Jul 26.【原文下载

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1976868, encodeId=ac1e19e686835, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sun Jul 13 16:10:00 CST 2014, time=2014-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915250, encodeId=fc6419152501b, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Feb 27 12:10:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084091, encodeId=28902084091d3, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Dec 31 22:10:00 CST 2013, time=2013-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857310, encodeId=35fb185e310ad, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 20 04:10:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813011, encodeId=74cd181301136, content=<a href='/topic/show?id=ea319163385' target=_blank style='color:#2F92EE;'>#诊断法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91633, encryptionId=ea319163385, topicName=诊断法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0041445, createdName=TZF0804, createdTime=Tue May 13 16:10:00 CST 2014, time=2014-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250928, encodeId=570112509284f, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sat Dec 07 02:10:00 CST 2013, time=2013-12-07, status=1, ipAttribution=)]
    2014-07-13 linlin2312
  2. [GetPortalCommentsPageByObjectIdResponse(id=1976868, encodeId=ac1e19e686835, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sun Jul 13 16:10:00 CST 2014, time=2014-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915250, encodeId=fc6419152501b, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Feb 27 12:10:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084091, encodeId=28902084091d3, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Dec 31 22:10:00 CST 2013, time=2013-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857310, encodeId=35fb185e310ad, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 20 04:10:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813011, encodeId=74cd181301136, content=<a href='/topic/show?id=ea319163385' target=_blank style='color:#2F92EE;'>#诊断法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91633, encryptionId=ea319163385, topicName=诊断法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0041445, createdName=TZF0804, createdTime=Tue May 13 16:10:00 CST 2014, time=2014-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250928, encodeId=570112509284f, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sat Dec 07 02:10:00 CST 2013, time=2013-12-07, status=1, ipAttribution=)]
    2014-02-27 rgjl
  3. [GetPortalCommentsPageByObjectIdResponse(id=1976868, encodeId=ac1e19e686835, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sun Jul 13 16:10:00 CST 2014, time=2014-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915250, encodeId=fc6419152501b, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Feb 27 12:10:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084091, encodeId=28902084091d3, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Dec 31 22:10:00 CST 2013, time=2013-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857310, encodeId=35fb185e310ad, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 20 04:10:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813011, encodeId=74cd181301136, content=<a href='/topic/show?id=ea319163385' target=_blank style='color:#2F92EE;'>#诊断法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91633, encryptionId=ea319163385, topicName=诊断法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0041445, createdName=TZF0804, createdTime=Tue May 13 16:10:00 CST 2014, time=2014-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250928, encodeId=570112509284f, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sat Dec 07 02:10:00 CST 2013, time=2013-12-07, status=1, ipAttribution=)]
    2013-12-31 xjy02
  4. [GetPortalCommentsPageByObjectIdResponse(id=1976868, encodeId=ac1e19e686835, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sun Jul 13 16:10:00 CST 2014, time=2014-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915250, encodeId=fc6419152501b, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Feb 27 12:10:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084091, encodeId=28902084091d3, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Dec 31 22:10:00 CST 2013, time=2013-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857310, encodeId=35fb185e310ad, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 20 04:10:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813011, encodeId=74cd181301136, content=<a href='/topic/show?id=ea319163385' target=_blank style='color:#2F92EE;'>#诊断法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91633, encryptionId=ea319163385, topicName=诊断法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0041445, createdName=TZF0804, createdTime=Tue May 13 16:10:00 CST 2014, time=2014-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250928, encodeId=570112509284f, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sat Dec 07 02:10:00 CST 2013, time=2013-12-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1976868, encodeId=ac1e19e686835, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sun Jul 13 16:10:00 CST 2014, time=2014-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915250, encodeId=fc6419152501b, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Feb 27 12:10:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084091, encodeId=28902084091d3, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Dec 31 22:10:00 CST 2013, time=2013-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857310, encodeId=35fb185e310ad, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 20 04:10:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813011, encodeId=74cd181301136, content=<a href='/topic/show?id=ea319163385' target=_blank style='color:#2F92EE;'>#诊断法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91633, encryptionId=ea319163385, topicName=诊断法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0041445, createdName=TZF0804, createdTime=Tue May 13 16:10:00 CST 2014, time=2014-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250928, encodeId=570112509284f, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sat Dec 07 02:10:00 CST 2013, time=2013-12-07, status=1, ipAttribution=)]
    2014-05-13 TZF0804
  6. [GetPortalCommentsPageByObjectIdResponse(id=1976868, encodeId=ac1e19e686835, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sun Jul 13 16:10:00 CST 2014, time=2014-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915250, encodeId=fc6419152501b, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Feb 27 12:10:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084091, encodeId=28902084091d3, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Dec 31 22:10:00 CST 2013, time=2013-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857310, encodeId=35fb185e310ad, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 20 04:10:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813011, encodeId=74cd181301136, content=<a href='/topic/show?id=ea319163385' target=_blank style='color:#2F92EE;'>#诊断法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91633, encryptionId=ea319163385, topicName=诊断法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0041445, createdName=TZF0804, createdTime=Tue May 13 16:10:00 CST 2014, time=2014-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250928, encodeId=570112509284f, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sat Dec 07 02:10:00 CST 2013, time=2013-12-07, status=1, ipAttribution=)]

相关资讯

美超声放射医师学会 2013 :妊娠失败新诊断标准

近期,美国超声放射医师学会提出了妊娠失败超声评估新标准 , 包括:头臀长度≥ 7 mm 且无心跳;孕囊平均直径≥ 25 mm且无胚胎;检查出无卵黄囊的孕囊 2 周后不见有心跳的胚胎;检查出有卵黄囊的孕囊 11 d 后仍不见有心跳的胚胎。(N Engl J Med. 2013, 369: 1443) 专家组指出,“盆腔超声检查和血清人绒毛膜促性腺激素(hCG)水平检测是诊断和处理妊娠早期疾病的基石

病例:妊娠合并肝病应急处理方案

    在几代妇产科医师的努力下,华中科技大学附属协和医院产科(协和医院产科)发展成今天集医疗、教学、科研于一体的全国临床重点专科,承担着湖北省及中南地区各级医院的急危重症、疑难杂症的转诊、会诊及抢救治疗任务。   该专科在原有基础上逐步形成由母体医学、胎儿医学、普通产科三个亚专科共同组成的专科。目前,已开展新式剖宫产技术(常规采用腹部横切口和皮内

AJG:妊娠中期炎症性肠病患者的不推荐应用抗肿瘤坏死因子类药物

研究要点: 1.抗肿瘤坏死因子药物在妊娠中后期可以透过胎盘,在乳汁中也可以检测到微量的抗肿瘤坏死因子药物。所以建议在妊娠中后期停药。 2.并未得出新生儿暴露于存在肿瘤坏死因子的环境中存在有害影响的结论。 抗肿瘤坏死因子药物在炎症性肠病患者中是一种效果较好的可选治疗方案。但是关于该类药物在女性患者妊娠期及哺乳期中使用的安全性的研究仍十分有限。西班牙马德里德拉普林医院胃肠病学科Javier

ESHRE 2013:子宫内膜瘤对妊娠能力无影响

伦敦——欧洲人类生殖与胚胎学会(ESHRE)年会上公布的一项研究显示,子宫内膜卵巢囊肿并不会降低自发排卵率和女性潜在妊娠能力。 研究者通过比较214例子宫内膜异位女性的健康卵巢和受累卵巢发现,在6个排卵周期内受累卵巢的总自发排卵率与健康卵巢相似,分别为50.3%和49.7%(P=0.919)。研究期间共对1,311个排卵周期进行了检查,不论子宫内膜瘤的患侧、数量或大小如何,所观察到的排卵率均相似

专家视角:妊娠合并糖尿病临床诊治中存在的问题

2013年8月22日--24日,第十二次全国内分泌学学术会议(CSE2013)在西安隆重召开。在8月23日上午的大会报告上,北京大学第一医院妇产科的杨慧霞教授报告《妊娠合并糖尿病临床诊治中存在的问题》。杨慧霞教授介绍了近年来我国在妊娠合并糖尿病临床诊治和研究方面所做的一些工作,并指出了现存的问题和未来需要改进的方向。 近年来,我国在妊娠合并糖尿病临床诊治和研究方面

妊娠与母体甲状腺功能异常1例报道

  妊娠期是机体一个特殊时期,因体内雌激素和绒毛膜促性腺激素(HCG)水平升高,使甲状腺激素的合成和代谢发生改变。妊娠期甲状腺功能(甲功)异常包括临床和亚临床甲状腺功能减退(甲减)、低T4血症、临床和亚临床甲状腺功能亢进(甲亢)及疑诊甲亢(体重不随妊娠月数相应增加或怕热、多汗、四肢消瘦或休息时心率在100次/分以上)。   目前,除亚临床甲亢外,其余的母体甲功异常均被发现可引

Baidu
map
Baidu
map
Baidu
map